Elicio Therapeutics • ELTX
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes.
Ratings
1 / 5
1 rating in the last 12 months
5
4
3
2
1
CEO
Mr. Robert Connelly$91.9M
Market Cap • 06/05/20242011
(há 13 anos)
2023
(1 year ago)
NASDAQ
Listagem
Boston
Sede • MassachusettsValuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ELTXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.